Cell, tissue and gene therapies – Regulatory challenges and responses in Australia | Hogan Lovells
Australian regulation of cell, tissue, and gene therapies (CTGT) is relatively new, with the regulatory framework for biological medical products first being introduced in 2011. A...
Source: jdsupra.com